former CEO · FENNEC PHARMACEUTICALS INC. (FENC)

Rostislav Raykov

A named executive officer of FENNEC PHARMACEUTICALS in every fiscal year CompBrief holds from FY2017 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$3,238,461

Salary $411,643Stock awards $712,000Bonus $611,339

FY2023: $2,540,940

1st of 4 named executive officers at Fennec Pharmaceuticals by FY2024 total.

4 named officers on file for FENNEC PHARMACEUTICALS, FY2024

Rostislav Raykov’s pay file — $29

  • 8 fiscal years of pay, line by line
  • FENC’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how FENNEC PHARMACEUTICALS’s whole pay program stands against its peers

  • FENNEC PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FENC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Rostislav Raykov’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Rostislav Raykov compensation by year

FENNEC PHARMACEUTICALS Summary Compensation Table · all 8 fiscal years held
In US dollars, as FENNEC PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Salary$262,500$350,000$488,692$430,000$468,452$503,436$607,061$411,643
Bonus$0$160,000$157,500$0$0$110,725$278,006$611,339
Stock awards$0$0$0$0$0$0$728,000$712,000
Option awards$187,579$562,261$830,944$1,694,216$2,951,923$0$927,873$894,792
Non-equity incentive$0$0$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$0$0$0$0$0$0$0$608,687
Total$450,079$1,072,261$1,476,536$1,476,536$3,420,375$614,161$2,540,940$3,238,461

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: FENNEC PHARMACEUTICALS INC. DEF 14A filed April 25, 2025, accession 0001558370-25-005563, and prior-year filings. Open the filing on EDGAR.

How this page was built: the FENNEC PHARMACEUTICALS INC. filed document, accession 0001558370-25-005563. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$450K
$1.1M
$1.5M
$1.5M
$3.4M
$614K
$2.5M
$3.2M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

FENNEC PHARMACEUTICALS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Rostislav Raykov · this pageformer CEO$3,238,461
Robert AndradeCFO$1,761,395
Jeffrey HackmanChief Executive Officer$1,611,862
Pierre SayadCMO$483,506

The full FENNEC PHARMACEUTICALS compensation record

free company brief

This page is one person within FENNEC PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the FENNEC PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are FENNEC PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rostislav Raykov's compensation dossier · One-time report. No refunds.